| Literature DB >> 25416534 |
Elisabet Arribas-Ibar, Albert Sánchez-Niubò, Xavier Majó, Antònia Domingo-Salvany1, Maria Teresa Brugal.
Abstract
BACKGROUND: The use of opiates, particularly heroin, remains an important cause of morbidity and mortality. Half of the deaths among heroin consumers are attributed to overdose. In response to this problem, overdose prevention programs (OPPs) were designed. The objective of our study was to assess coverage of OPPs among the target population in a specific Spanish region (Catalonia) and to identify characteristics related to attendance.Entities:
Mesh:
Year: 2014 PMID: 25416534 PMCID: PMC4247710 DOI: 10.1186/1477-7517-11-33
Source DB: PubMed Journal: Harm Reduct J ISSN: 1477-7517
Overdose prevention program (OPP) coverage by recruitment center and geographical area
| Attendance to OPP | ||||
|---|---|---|---|---|
|
| Yes | |||
|
|
|
|
|
|
| Outpatient treatment center | 156 | 50 | 32.1 | (27%–37%) |
| Therapeutic communities | 54 | 19 | 35.2 | (30%–41%) |
| Harm reduction facilities | 96 | 64 | 66.7 | (61%–72%) |
|
|
| |||
| Barcelona | 130 | 66 | 50.8 | (45%–56%) |
| BMC | 49 | 29 | 59.2 | (54%–65%) |
| More than 100,000 inhabitantsa | 63 | 27 | 42.9 | (37%–49%) |
| 10,001 to 100,000 inhabitantsa | 37 | 9 | 24.3 | (19%–29%) |
| Up to 10,000 inhabitantsa | 26 | 2 | 7.7 | (5%–11%) |
|
|
| |||
| Barcelona and BMC | 176 | 92 | 52.3 | (47%–58%) |
| Barcelonaa | 56 | 19 | 33.9 | (29%–39%) |
| Tarragona | 28 | 4 | 14.3 | (10%–18%) |
| Lleida | 20 | 10 | 50 | (44%–56%) |
| Girona | 20 | 5 | 25 | (20%–30%) |
BMC Barcelona metropolitan conurbation.
aWithout Barcelona or BMC.
Socio-demographic and psychoactive substance use patterns associated to participation in overdose prevention programs (OPPs)
| Attendance to OPP | Bivariate poisson | Multiple poisson | |||||
|---|---|---|---|---|---|---|---|
| Regression a | Regression a | ||||||
|
| Yes | PR | 95% CI | PR | 95% CI | ||
|
| % | ||||||
|
| |||||||
|
|
| ||||||
| Spain | 273 | 112 | 41 | 1 | 1 | ||
| Other countriesb | 33 | 21 | 63.6 | 1.5 | (1.12–2.03)* | 1.3 | (1.04–1.72)* |
|
|
| ||||||
| Less than 100,000 inhabitants; not BMC | 63 | 11 | 17.5 | 1 | 1 | ||
| More than 100,000 inhabitants; not BMC | 52 | 20 | 38.5 | 2.2 | (1.49–3.23)* | 2.0 | (1.37–2.81)* |
| Barcelona and BMC | 190 | 102 | 53.7 | 3.1 | (1.98–4.84)* | 2.5 | (1.68–3.77)* |
|
|
| ||||||
| High school/university degree | 73 | 26 | 35.6 | 1 | |||
| Secondary education | 121 | 55 | 45.5 | 1.3 | (0.87–1.81) | ||
| Primary/elementary | 112 | 52 | 46.4 | 1.3 | (1.01–1.89)* | ||
|
|
| ||||||
| Working | 36 | 7 | 19.4 | 1 | |||
| Never worked/unemployed | 170 | 77 | 45.3 | 2.4 | (0.95–6.02) | ||
| Permanent disability/pensioner | 79 | 40 | 50.6 | 2.9 | (1.23–6.60)* | ||
| Student/sporadic work/working at home | 17 | 8 | 47.1 | 2.6 | (0.67–10.10) | ||
|
|
| ||||||
| No | 131 | 36 | 27.5 | 1 | 1 | ||
| Yes | 173 | 95 | 54.9 | 2.0 | (1.78–2.30)* | 1.6 | (1.41–1.81)* |
|
| |||||||
|
|
| ||||||
| ≥13 years | 249 | 100 | 40.2 | 1 | 1 | ||
| ≤12 years | 56 | 33 | 58.9 | 1.4 | (1.19–1.75)* | 1.2 | (1.06–1.45)* |
|
|
| ||||||
| Cannabis (marijuana, hashish) | 232 | 101 | 43.5 | 1 | |||
| Cocaine, heroin, her-coca, crack | 48 | 23 | 47.9 | 1.1 | (0.88–1.44) | ||
| Other drugsc | 24 | 8 | 33.3 | 0.8 | (0.40–1.43) | ||
|
|
| ||||||
| No | 87 | 31 | 35.6 | 1 | |||
| Yes | 219 | 102 | 46.6 | 1.3 | (1.03–1.70)* | ||
|
|
| ||||||
| No | 16 | 7 | 43.8 | 1 | |||
| Yes | 290 | 126 | 43.4 | 1.0 | (0.70–1.47) | ||
|
|
| ||||||
| No | 167 | 73 | 43.7 | 1 | |||
| Yes | 139 | 60 | 43.2 | 0.9 | (0.75–1.24) | ||
CI confidence interval, PR prevalence ratio, BMC Barcelona metropolitan conurbation.
*p <0.05.
aPoisson regression with robust variance adjusted by age and sex, using generalized estimated equations to control correlation within recruitment center.
bOther countries: rest of Europe, America, Asia, and North Africa.
cOther drugs: include tranquilizers, mushrooms, LSD, and ketamine.
dAccording to AUDIT [26].